CytoDyn Inc. Files 424B3 Prospectus
Ticker: CYDY · Form: 424B3 · Filed: 2026-04-08T17:15:18-04:00
Sentiment: neutral
Topics: prospectus, securities-offering, pharmaceutical
TL;DR
CytoDyn filed a prospectus update on 4/8/26. Keep an eye on potential stock offerings.
AI Summary
CytoDyn Inc. filed a 424B3 prospectus on April 8, 2026, related to its registration statement for securities. The filing details the company's business and financial information as required for public offerings. CytoDyn Inc. is a pharmaceutical company based in Vancouver, WA.
Why It Matters
This filing is a routine prospectus update, indicating potential ongoing or future securities offerings by CytoDyn Inc. It provides updated information for investors regarding the company's offerings.
Risk Assessment
Risk Level: medium — Prospectus filings can precede stock offerings, which may dilute existing shareholders or signal a need for capital, impacting stock price.
Key Numbers
- 333-282000 — File Number (Associated with the registration statement for the prospectus)
- 26849007 — Film Number (SEC processing number for the filing)
Key Players & Entities
- CytoDyn Inc. (company) — Filer of the 424B3 prospectus
- 0001175680 (company) — CIK number for CytoDyn Inc.
- 2026-04-08 (date) — Filing date of the 424B3 prospectus
- 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 (address) — Mailing and Business Address for CytoDyn Inc.
FAQ
What type of filing is this 424B3?
This is a prospectus filing, specifically under Rule 424(b)(3), which relates to the registration of securities.
When was this filing accepted by the SEC?
The filing was accepted on April 8, 2026, at 17:15:18.
What is the CIK number for CytoDyn Inc.?
The CIK number for CytoDyn Inc. is 0001175680.
Where is CytoDyn Inc. located?
CytoDyn Inc.'s business and mailing address is 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660.
What is the SIC code for CytoDyn Inc.?
The SIC code for CytoDyn Inc. is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001104659-26-041012 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B3 - Prospectus [Rule 424(b)(3)]: SEC Accession No. 0001104659-26-041012 Filing Date 2026-04-08 Accepted 2026-04-08 17:15:18 Documents 2 Document Format Files Seq Description Document Type Size 1 424B3 cydy-20260408x424b3.htm 424B3 1652908 2 GRAPHIC cydy-20260408x424b3_a001.jpg GRAPHIC 14061 Complete submission text file 0001104659-26-041012.txt 1673603 Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524 CytoDyn Inc. (Filer) CIK : 0001175680 (see all company filings) EIN. : 753056237 | State of Incorp.: DE | Fiscal Year End: 0531 Type: 424B3 | Act: 33 | File No.: 333-282000 | Film No.: 26849007 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)